AccuLine
Preventing the next Heart Attack
StartupAccuLine is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2022. Preventing the next Heart Attack. The company has raised a total of $6.25M across 5 funding rounds, currently at the Pre-Seed stage. AccuLine was founded by Moshe Barel, Aaron Frimerman, Shai Revzen. Key investors include eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s), among 4 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Machine Learning, Data Storage, Cloud.
With $6.25M in total funding, AccuLine is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Seed
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQPetah Tikva
- Last Round$600K
- eHealth Ventures
- Maccabi Healthcare Services
- Undisclosed Investor(s)
4 investors total
Moshe BarelCEO
Aaron FrimermanCMO
Shai RevzenCSO
5 articles covered by sources including www.calcalistech.com,
www.geektime.co.il,
www.prnewswire.com,
www.ynet.co.il.
What does AccuLine do?
AccuLine was founded with the vision to save the lives of millions of people worldwide by preventing the next heart attack. AccuLine is developing CORA – an accurate, non-invasive, swift, and cost-effective examination for early detection of CAD, designed to replace the inaccurate, time-consuming, and labor-intensive stress test examinations. Through a brief 4-minute evaluation of three vital signs - the heart's electrical activity, oxygen saturation levels, and respiratory phase, CORA automatically generates results, ensuring a seamless and efficient process. CORA has the potential to save the lives of millions of patients worldwide, while simultaneously decreasing health care-related costs. AccuLine has received grants from Google and the Israeli Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
How much funding has AccuLine raised?
AccuLine has raised $6.25M in total funding across 5 rounds. The company is currently at the Pre-Seed stage. Key investors include eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s).
Who founded AccuLine?
AccuLine was founded in 2022 by Moshe Barel (CEO), Aaron Frimerman (CMO), Shai Revzen (CSO).
What sector is AccuLine in?
AccuLine operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Artificial Intelligence, Machine Learning, Data Storage, Cloud. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is AccuLine located?
AccuLine is based in Park Ofer, הפסגות 9, פתח תקווה, Israel.